instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'LINEZOLID'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | Oral | DrugAdministrationRoute | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'ACETAMINOPHEN'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'ACETAMINOPHEN\OXYCODONE HYDROCHLORIDE'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'ALLOPURINOL'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'AMLODIPINE BESYLATE'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'AMOXICILLIN\CLAVULANIC ACID'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'ASCORBIC ACID\BIOTIN\CYANOCOBALAMIN\FOLIC ACID\NIACIN\PANTOTHENIC ACID\PYRIDOXINE\RIBOFLAVIN\THIAMINE'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'ATORVASTATIN'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'BENZONATATE'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'CARVEDILOL'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'CHOLECALCIFEROL'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'CINACALCET'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'CLONAZEPAM'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'DEXTROSE'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | 3 CYCLES, 150 MIN FOR EACH CYCLE | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'HYDROXYZINE HYDROCHLORIDE'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'PANTOPRAZOLE'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'PIPERACILLIN SODIUM\TAZOBACTAM SODIUM'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the dosage of drug 'SEVELAMER CARBONATE'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | UNKNOWN | DrugDosageText | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the outcome of reaction 'Dizziness'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | Recovered | ReactionOutcome | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
What was the outcome of reaction 'Vestibular disorder'? | Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review.
Peritoneal dialysis associated infections are common and associated with high morbidity and mortality, if not treated in a timely manner. Mycobacterium abscessus is an uncommon pathogen in peritoneal dial... | Recovered | ReactionOutcome | CC BY | 33985367 | 19,427,127 | 2021-05-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.
Primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) is a very rare lymphoma with an aggressive clinical course and a dismal outcome. The prognosis is linked to a pronou... | BRENTUXIMAB VEDOTIN, CYCLOPHOSPHAMIDE, CYTARABINE, DOXORUBICIN, ETOPOSIDE, METHOTREXATE, METHYLPREDNISOLONE, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY | 33985594 | 20,150,087 | 2021-05-13 |
What was the administration route of drug 'BRENTUXIMAB VEDOTIN'? | Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.
Primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) is a very rare lymphoma with an aggressive clinical course and a dismal outcome. The prognosis is linked to a pronou... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33985594 | 20,150,087 | 2021-05-13 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.
Primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) is a very rare lymphoma with an aggressive clinical course and a dismal outcome. The prognosis is linked to a pronou... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33985594 | 20,150,087 | 2021-05-13 |
What was the administration route of drug 'CYTARABINE'? | Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.
Primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) is a very rare lymphoma with an aggressive clinical course and a dismal outcome. The prognosis is linked to a pronou... | Intrathecal | DrugAdministrationRoute | CC BY | 33985594 | 20,150,087 | 2021-05-13 |
What was the administration route of drug 'DOXORUBICIN'? | Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.
Primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) is a very rare lymphoma with an aggressive clinical course and a dismal outcome. The prognosis is linked to a pronou... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33985594 | 20,150,087 | 2021-05-13 |
What was the administration route of drug 'ETOPOSIDE'? | Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.
Primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) is a very rare lymphoma with an aggressive clinical course and a dismal outcome. The prognosis is linked to a pronou... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33985594 | 20,150,087 | 2021-05-13 |
What was the administration route of drug 'METHOTREXATE'? | Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.
Primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) is a very rare lymphoma with an aggressive clinical course and a dismal outcome. The prognosis is linked to a pronou... | Intrathecal | DrugAdministrationRoute | CC BY | 33985594 | 20,150,087 | 2021-05-13 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.
Primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) is a very rare lymphoma with an aggressive clinical course and a dismal outcome. The prognosis is linked to a pronou... | Intrathecal | DrugAdministrationRoute | CC BY | 33985594 | 20,150,087 | 2021-05-13 |
What was the administration route of drug 'PREDNISONE'? | Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.
Primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) is a very rare lymphoma with an aggressive clinical course and a dismal outcome. The prognosis is linked to a pronou... | Oral | DrugAdministrationRoute | CC BY | 33985594 | 20,150,087 | 2021-05-13 |
What was the administration route of drug 'VINCRISTINE'? | Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.
Primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) is a very rare lymphoma with an aggressive clinical course and a dismal outcome. The prognosis is linked to a pronou... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33985594 | 20,150,087 | 2021-05-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Endometrial cancer'. | Development of endometrial cancer after long-term usage of the levonorgestrel-releasing intrauterine system.
A 52-year-old long-term user of the levonorgestrel-releasing intrauterine system (LNG-IUS) presented with vaginal bleeding. Endometrial biopsy was performed and revealed endometrioid adenocarcinoma. The patient ... | LEVONORGESTREL | DrugsGivenReaction | CC BY-NC | 33986013 | 19,352,395 | 2021-05-13 |
What was the administration route of drug 'LEVONORGESTREL'? | Development of endometrial cancer after long-term usage of the levonorgestrel-releasing intrauterine system.
A 52-year-old long-term user of the levonorgestrel-releasing intrauterine system (LNG-IUS) presented with vaginal bleeding. Endometrial biopsy was performed and revealed endometrioid adenocarcinoma. The patient ... | Intra-uterine | DrugAdministrationRoute | CC BY-NC | 33986013 | 19,352,395 | 2021-05-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardio-respiratory arrest'. | Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia.
Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). It has mainly been used in the treatment of osteoporosis for a variety of causes especially in situations ... | DENOSUMAB, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, PYRIDOXINE, RIFAMPIN | DrugsGivenReaction | CC BY | 33986809 | 19,295,425 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effective for unapproved indication'. | Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia.
Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). It has mainly been used in the treatment of osteoporosis for a variety of causes especially in situations ... | DENOSUMAB, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, PYRIDOXINE, RIFAMPIN | DrugsGivenReaction | CC BY | 33986809 | 19,295,425 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia.
Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). It has mainly been used in the treatment of osteoporosis for a variety of causes especially in situations ... | DENOSUMAB, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, PYRIDOXINE, RIFAMPIN | DrugsGivenReaction | CC BY | 33986809 | 19,295,425 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia.
Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). It has mainly been used in the treatment of osteoporosis for a variety of causes especially in situations ... | DENOSUMAB, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, PYRIDOXINE, RIFAMPIN | DrugsGivenReaction | CC BY | 33986809 | 19,295,425 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia.
Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). It has mainly been used in the treatment of osteoporosis for a variety of causes especially in situations ... | DENOSUMAB, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, PYRIDOXINE, RIFAMPIN | DrugsGivenReaction | CC BY | 33986809 | 19,295,425 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia.
Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). It has mainly been used in the treatment of osteoporosis for a variety of causes especially in situations ... | DENOSUMAB, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, PYRIDOXINE, RIFAMPIN | DrugsGivenReaction | CC BY | 33986809 | 19,295,425 | 2021 |
What was the administration route of drug 'DENOSUMAB'? | Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia.
Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). It has mainly been used in the treatment of osteoporosis for a variety of causes especially in situations ... | Subcutaneous | DrugAdministrationRoute | CC BY | 33986809 | 19,295,425 | 2021 |
What was the outcome of reaction 'Cardio-respiratory arrest'? | Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia.
Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). It has mainly been used in the treatment of osteoporosis for a variety of causes especially in situations ... | Fatal | ReactionOutcome | CC BY | 33986809 | 19,295,425 | 2021 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia.
Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). It has mainly been used in the treatment of osteoporosis for a variety of causes especially in situations ... | Fatal | ReactionOutcome | CC BY | 33986809 | 19,295,425 | 2021 |
What was the outcome of reaction 'Pneumonia'? | Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia.
Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). It has mainly been used in the treatment of osteoporosis for a variety of causes especially in situations ... | Fatal | ReactionOutcome | CC BY | 33986809 | 19,295,425 | 2021 |
What was the outcome of reaction 'Respiratory failure'? | Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia.
Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). It has mainly been used in the treatment of osteoporosis for a variety of causes especially in situations ... | Fatal | ReactionOutcome | CC BY | 33986809 | 19,295,425 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Methaemoglobinaemia'. | Rasburicase-Induced Methemoglobinemia.
Methemoglobinemia occurs as iron in heme is oxidized to its ferric state, resulting in a decreased ability of hemoglobin to bind and release oxygen. Rasburicase is a recombinant urate-oxidase enzyme used in the prevention of tumor lysis syndrome. Methemoglobinemia can occur as a r... | RASBURICASE | DrugsGivenReaction | CC BY | 33987056 | 16,970,961 | 2021-04-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Rasburicase-Induced Methemoglobinemia.
Methemoglobinemia occurs as iron in heme is oxidized to its ferric state, resulting in a decreased ability of hemoglobin to bind and release oxygen. Rasburicase is a recombinant urate-oxidase enzyme used in the prevention of tumor lysis syndrome. Methemoglobinemia can occur as a r... | RASBURICASE | DrugsGivenReaction | CC BY | 33987056 | 16,970,961 | 2021-04-10 |
What was the outcome of reaction 'Methaemoglobinaemia'? | Rasburicase-Induced Methemoglobinemia.
Methemoglobinemia occurs as iron in heme is oxidized to its ferric state, resulting in a decreased ability of hemoglobin to bind and release oxygen. Rasburicase is a recombinant urate-oxidase enzyme used in the prevention of tumor lysis syndrome. Methemoglobinemia can occur as a r... | Fatal | ReactionOutcome | CC BY | 33987056 | 16,970,961 | 2021-04-10 |
What was the outcome of reaction 'Respiratory failure'? | Rasburicase-Induced Methemoglobinemia.
Methemoglobinemia occurs as iron in heme is oxidized to its ferric state, resulting in a decreased ability of hemoglobin to bind and release oxygen. Rasburicase is a recombinant urate-oxidase enzyme used in the prevention of tumor lysis syndrome. Methemoglobinemia can occur as a r... | Fatal | ReactionOutcome | CC BY | 33987056 | 16,970,961 | 2021-04-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemophagocytic lymphohistiocytosis'. | Lenalidomide-Associated Hemophagocytic Lymphohistiocytosis With Plasma Cell Phagocytosis.
Hemophagocytic lymphohistiocytosis (HLH) is a severe systemic inflammatory syndrome that is often fatal. In the adult population, it is believed to develop secondary to immune dysregulation due to rheumatologic, infectious, malign... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 33987058 | 19,303,407 | 2021-04-10 |
What was the administration route of drug 'LENALIDOMIDE'? | Lenalidomide-Associated Hemophagocytic Lymphohistiocytosis With Plasma Cell Phagocytosis.
Hemophagocytic lymphohistiocytosis (HLH) is a severe systemic inflammatory syndrome that is often fatal. In the adult population, it is believed to develop secondary to immune dysregulation due to rheumatologic, infectious, malign... | Oral | DrugAdministrationRoute | CC BY | 33987058 | 19,303,407 | 2021-04-10 |
What was the dosage of drug 'BORTEZOMIB'? | Lenalidomide-Associated Hemophagocytic Lymphohistiocytosis With Plasma Cell Phagocytosis.
Hemophagocytic lymphohistiocytosis (HLH) is a severe systemic inflammatory syndrome that is often fatal. In the adult population, it is believed to develop secondary to immune dysregulation due to rheumatologic, infectious, malign... | 6 CYCLES | DrugDosageText | CC BY | 33987058 | 19,303,407 | 2021-04-10 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Lenalidomide-Associated Hemophagocytic Lymphohistiocytosis With Plasma Cell Phagocytosis.
Hemophagocytic lymphohistiocytosis (HLH) is a severe systemic inflammatory syndrome that is often fatal. In the adult population, it is believed to develop secondary to immune dysregulation due to rheumatologic, infectious, malign... | 6 CYCLES | DrugDosageText | CC BY | 33987058 | 19,303,407 | 2021-04-10 |
What was the dosage of drug 'DEXAMETHASONE'? | Lenalidomide-Associated Hemophagocytic Lymphohistiocytosis With Plasma Cell Phagocytosis.
Hemophagocytic lymphohistiocytosis (HLH) is a severe systemic inflammatory syndrome that is often fatal. In the adult population, it is believed to develop secondary to immune dysregulation due to rheumatologic, infectious, malign... | 6 CYCLES, TAPER | DrugDosageText | CC BY | 33987058 | 19,303,407 | 2021-04-10 |
What was the dosage of drug 'LENALIDOMIDE'? | Lenalidomide-Associated Hemophagocytic Lymphohistiocytosis With Plasma Cell Phagocytosis.
Hemophagocytic lymphohistiocytosis (HLH) is a severe systemic inflammatory syndrome that is often fatal. In the adult population, it is believed to develop secondary to immune dysregulation due to rheumatologic, infectious, malign... | MAINTENANCE DOSE | DrugDosageText | CC BY | 33987058 | 19,303,407 | 2021-04-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Ipilimumab and Nivolumab-Induced Colitis in a Patient With Recurrent Metastatic Melanoma.
Ipilimumab and nivolumab are immune checkpoint inhibitors that have recently been used in the treatment of metastatic melanoma and other cancers. Immune-mediated colitis is one of their adverse events that need to be differentiate... | DIPHENOXYLATE, LOPERAMIDE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33987063 | 18,680,026 | 2021-04-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated enterocolitis'. | Ipilimumab and Nivolumab-Induced Colitis in a Patient With Recurrent Metastatic Melanoma.
Ipilimumab and nivolumab are immune checkpoint inhibitors that have recently been used in the treatment of metastatic melanoma and other cancers. Immune-mediated colitis is one of their adverse events that need to be differentiate... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY | 33987063 | 18,679,492 | 2021-04-11 |
What was the outcome of reaction 'Immune-mediated enterocolitis'? | Ipilimumab and Nivolumab-Induced Colitis in a Patient With Recurrent Metastatic Melanoma.
Ipilimumab and nivolumab are immune checkpoint inhibitors that have recently been used in the treatment of metastatic melanoma and other cancers. Immune-mediated colitis is one of their adverse events that need to be differentiate... | Recovering | ReactionOutcome | CC BY | 33987063 | 18,679,492 | 2021-04-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Central nervous system lymphoma'. | Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors.
Cardiac lymphomas are rare extranodal lymphomas involving primarily and secondarily the heart and/or pericardium. Here we describe three cases of cardiac involvement from lymphoma with specific peculiarities: two ... | CYCLOPHOSPHAMIDE, CYTARABINE, DOXORUBICIN HYDROCHLORIDE, METHOTREXATE, PREDNISONE, RITUXIMAB, THIOTEPA, VINCRISTINE | DrugsGivenReaction | CC BY | 33987101 | 20,083,404 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors.
Cardiac lymphomas are rare extranodal lymphomas involving primarily and secondarily the heart and/or pericardium. Here we describe three cases of cardiac involvement from lymphoma with specific peculiarities: two ... | CYCLOPHOSPHAMIDE, CYTARABINE, DOXORUBICIN HYDROCHLORIDE, METHOTREXATE, PREDNISONE, RITUXIMAB, THIOTEPA, VINCRISTINE | DrugsGivenReaction | CC BY | 33987101 | 20,083,404 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm recurrence'. | Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors.
Cardiac lymphomas are rare extranodal lymphomas involving primarily and secondarily the heart and/or pericardium. Here we describe three cases of cardiac involvement from lymphoma with specific peculiarities: two ... | CYCLOPHOSPHAMIDE, CYTARABINE, DOXORUBICIN HYDROCHLORIDE, METHOTREXATE, PREDNISONE, RITUXIMAB, THIOTEPA, VINCRISTINE | DrugsGivenReaction | CC BY | 33987101 | 20,083,404 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors.
Cardiac lymphomas are rare extranodal lymphomas involving primarily and secondarily the heart and/or pericardium. Here we describe three cases of cardiac involvement from lymphoma with specific peculiarities: two ... | CYTARABINE, DEXAMETHASONE, METHOTREXATE, METHYLPREDNISOLONE, RITUXIMAB, TEMOZOLOMIDE, THIOTEPA | DrugsGivenReaction | CC BY | 33987101 | 19,445,576 | 2021 |
What was the dosage of drug 'AMIODARONE'? | Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors.
Cardiac lymphomas are rare extranodal lymphomas involving primarily and secondarily the heart and/or pericardium. Here we describe three cases of cardiac involvement from lymphoma with specific peculiarities: two ... | UNKNOWN | DrugDosageText | CC BY | 33987101 | 19,419,332 | 2021 |
What was the dosage of drug 'METHOTREXATE SODIUM'? | Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors.
Cardiac lymphomas are rare extranodal lymphomas involving primarily and secondarily the heart and/or pericardium. Here we describe three cases of cardiac involvement from lymphoma with specific peculiarities: two ... | 1 CYCLIC | DrugDosageText | CC BY | 33987101 | 19,413,419 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors.
Cardiac lymphomas are rare extranodal lymphomas involving primarily and secondarily the heart and/or pericardium. Here we describe three cases of cardiac involvement from lymphoma with specific peculiarities: two ... | Fatal | ReactionOutcome | CC BY | 33987101 | 20,206,257 | 2021 |
What was the outcome of reaction 'Central nervous system lymphoma'? | Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors.
Cardiac lymphomas are rare extranodal lymphomas involving primarily and secondarily the heart and/or pericardium. Here we describe three cases of cardiac involvement from lymphoma with specific peculiarities: two ... | Fatal | ReactionOutcome | CC BY | 33987101 | 20,206,257 | 2021 |
What was the outcome of reaction 'Disease progression'? | Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors.
Cardiac lymphomas are rare extranodal lymphomas involving primarily and secondarily the heart and/or pericardium. Here we describe three cases of cardiac involvement from lymphoma with specific peculiarities: two ... | Fatal | ReactionOutcome | CC BY | 33987101 | 20,083,404 | 2021 |
What was the outcome of reaction 'Drug intolerance'? | Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors.
Cardiac lymphomas are rare extranodal lymphomas involving primarily and secondarily the heart and/or pericardium. Here we describe three cases of cardiac involvement from lymphoma with specific peculiarities: two ... | Fatal | ReactionOutcome | CC BY | 33987101 | 20,206,257 | 2021 |
What was the outcome of reaction 'Neoplasm recurrence'? | Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors.
Cardiac lymphomas are rare extranodal lymphomas involving primarily and secondarily the heart and/or pericardium. Here we describe three cases of cardiac involvement from lymphoma with specific peculiarities: two ... | Fatal | ReactionOutcome | CC BY | 33987101 | 20,206,257 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | ALBUTEROL, ASCORBIC ACID, AZITHROMYCIN ANHYDROUS, BUDESONIDE\FORMOTEROL FUMARATE, CEFOPERAZONE\SULBACTAM, DEXAMETHASONE, DOXYCYCLINE, HEPARIN SODIUM, IVERMECTIN, METHYLPREDNISOLONE, OXYGEN, PANTOPRAZOLE, REMDESIVIR | DrugsGivenReaction | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the administration route of drug 'ALBUTEROL'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the administration route of drug 'ASCORBIC ACID'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | Oral | DrugAdministrationRoute | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the administration route of drug 'AZITHROMYCIN ANHYDROUS'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | Oral | DrugAdministrationRoute | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the administration route of drug 'BUDESONIDE\FORMOTEROL FUMARATE'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the administration route of drug 'CEFOPERAZONE\SULBACTAM'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the administration route of drug 'DEXAMETHASONE'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | Oral | DrugAdministrationRoute | CC BY | 33987731 | 19,419,729 | 2021-05-14 |
What was the administration route of drug 'DOXYCYCLINE'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | Oral | DrugAdministrationRoute | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the administration route of drug 'HEPARIN SODIUM'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | Subcutaneous | DrugAdministrationRoute | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the administration route of drug 'IVERMECTIN'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | Oral | DrugAdministrationRoute | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | Oral | DrugAdministrationRoute | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the administration route of drug 'OXYGEN'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the administration route of drug 'PANTOPRAZOLE'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | Oral | DrugAdministrationRoute | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the administration route of drug 'REMDESIVIR'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the dosage of drug 'CEFOPERAZONE\SULBACTAM'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | 1000 MG PLUS 1000 MG | DrugDosageText | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the dosage of drug 'HEPARIN SODIUM'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | 5000 UNITS | DrugDosageText | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the dosage of drug 'OXYGEN'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | 2 LITRES/MINUTE | DrugDosageText | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the dosage of drug 'REMDESIVIR'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | LOADING DOSE | DrugDosageText | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
What was the outcome of reaction 'Chorioretinopathy'? | "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.
BACKGROUND
Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female... | Recovering | ReactionOutcome | CC BY | 33987731 | 19,407,762 | 2021-05-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucosal inflammation'. | Bendamustine-induced nephrogenic diabetes insipidus - A case report.
BACKGROUND
In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine,... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, CYTARABINE, DOXORUBICIN, ETOPOSIDE, FUROSEMIDE, MELPHALAN, PLERIXAFOR, POTASSIUM CHLORIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE, VITAMIN D NOS | DrugsGivenReaction | CC BY | 33990157 | 20,295,014 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Odynophagia'. | Bendamustine-induced nephrogenic diabetes insipidus - A case report.
BACKGROUND
In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine,... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, CYTARABINE, DOXORUBICIN, ETOPOSIDE, FUROSEMIDE, MELPHALAN, PLERIXAFOR, POTASSIUM CHLORIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE, VITAMIN D NOS | DrugsGivenReaction | CC BY | 33990157 | 20,295,014 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Bendamustine-induced nephrogenic diabetes insipidus - A case report.
BACKGROUND
In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine,... | DESMOPRESSIN | DrugsGivenReaction | CC BY | 33990157 | 20,319,610 | 2022-01 |
What was the administration route of drug 'BENDAMUSTINE'? | Bendamustine-induced nephrogenic diabetes insipidus - A case report.
BACKGROUND
In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine,... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33990157 | 20,295,014 | 2022-01 |
What was the administration route of drug 'CYTARABINE'? | Bendamustine-induced nephrogenic diabetes insipidus - A case report.
BACKGROUND
In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine,... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33990157 | 20,295,014 | 2022-01 |
What was the administration route of drug 'ETOPOSIDE'? | Bendamustine-induced nephrogenic diabetes insipidus - A case report.
BACKGROUND
In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine,... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33990157 | 20,295,014 | 2022-01 |
What was the administration route of drug 'MELPHALAN'? | Bendamustine-induced nephrogenic diabetes insipidus - A case report.
BACKGROUND
In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine,... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33990157 | 20,295,014 | 2022-01 |
What was the dosage of drug 'BENDAMUSTINE'? | Bendamustine-induced nephrogenic diabetes insipidus - A case report.
BACKGROUND
In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine,... | 200 MILLIGRAM/SQ. METER, ONE DOSE EACH ON DAYS -8 AND -7 | DrugDosageText | CC BY | 33990157 | 20,295,014 | 2022-01 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Bendamustine-induced nephrogenic diabetes insipidus - A case report.
BACKGROUND
In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine,... | UNK UNK, CYCLICAL, THREE CYCLES OF R-MAXI CHOP REGIMEN | DrugDosageText | CC BY | 33990157 | 20,295,014 | 2022-01 |
What was the dosage of drug 'DOXORUBICIN'? | Bendamustine-induced nephrogenic diabetes insipidus - A case report.
BACKGROUND
In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine,... | UNK UNK, CYCLICAL, THREE CYCLES OF R-MAXI CHOP REGIMEN | DrugDosageText | CC BY | 33990157 | 20,295,014 | 2022-01 |
What was the dosage of drug 'ETOPOSIDE'? | Bendamustine-induced nephrogenic diabetes insipidus - A case report.
BACKGROUND
In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine,... | 100 MILLIGRAM/SQ. METER, ON DAYS -6 TO -3 | DrugDosageText | CC BY | 33990157 | 20,295,014 | 2022-01 |
What was the dosage of drug 'MELPHALAN'? | Bendamustine-induced nephrogenic diabetes insipidus - A case report.
BACKGROUND
In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine,... | 140 MILLIGRAM/SQ. METER (ON DAY -2) | DrugDosageText | CC BY | 33990157 | 20,295,014 | 2022-01 |
What was the dosage of drug 'PREDNISOLONE'? | Bendamustine-induced nephrogenic diabetes insipidus - A case report.
BACKGROUND
In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine,... | UNK, CYCLICAL, THREE CYCLES OF R-MAXI CHOP REGIMEN | DrugDosageText | CC BY | 33990157 | 20,295,014 | 2022-01 |
What was the dosage of drug 'VINCRISTINE'? | Bendamustine-induced nephrogenic diabetes insipidus - A case report.
BACKGROUND
In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine,... | UNK UNK, CYCLICAL, THREE CYCLES OF R-MAXI CHOP REGIMEN | DrugDosageText | CC BY | 33990157 | 20,295,014 | 2022-01 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.